Commenting on the re-opening, Sheikh Faisal Bin Qassim Al Thani said: “It is my pleasure to see the introduction of this new technology at Ebn Sina Pharmacy in City Center. This follows its complete renovation and the implementation of cutting-edge technology, with the installation of the first robot in Qatar’s private pharmacy sector. Aamal closely follows the latest developments in international automation and we are always keen to introduce the latest technologies to the Qatari market. This is also a great opportunity to personally thank all our colleagues for their exceptional efforts and continuous commitment”.
Mr. Sherif Shehata - General Manager of Ebn Sina Medical – commented: “We are always looking to implement the latest technologies across all our operations, including our retail pharmacies, and we achieve this through partnering with international suppliers and market-leaders in the medical sector.
In 2019 our main objective is to maintain our market-leading position and our ongoing growth, and we look forward to continuing to address growing market demands and challenges by collaborating with leading pharmaceuticals and medical equipment companies”.
Ebn Sina Pharmacy in City Center started operating at the beginning of 2001, and it is one of the leading pharmacies in Doha, with a market-leading position amongst pharmacies in Qatar.
As well as Ebn Sina Pharmacy in City Center, Ebn Sina Pharmacy in Ras Abu-Aboud was successfully opened in July 2018 and there are plans to open a third state-of-the-art pharmacy at the Rail Project in Mushaireb Metro Station.
This announcement is not considered price-sensitive information. Referencing Articles (47), (50), and (58) of QFMA’s Rulebook on Offering and Listing of Securities and QFMA’s instructions on the disclosure of significant non-financial information that has impact on the share price of a listed company, this corporate development doesn’t fall under the scope of the rules and regulations concerning disclosing non-financial price-sensitive information.
For further enquiries, please contact:
Aamal Company Q.P.S.C.:
Laura Ackel – Marketing and Communications Officer
Aamal Company Q.P.S.C.:
Aamal is one of the region’s fastest growing diversified conglomerates and has been listed on the Qatar Stock Exchange since December 2007. As at 20 May 2019, the Company had a market capitalisation of QAR 5.0 bn (US$ 1.4 bn).
Aamal’s operations are widely diversified and comprise 26 active business units (subsidiaries and joint ventures) with market leading positions in the key industrial, retail, property, managed services, and medical equipment and pharmaceutical sectors, thereby offering investors a high quality and balanced exposure to Qatar’s wider economic growth and development. Aamal is focused on self-financed and profitable growth, delivering an average increase in underlying profits in excess of 11.1% (i.e. before fair value gains on investment properties) over the twelve years to end-2018.
For further information on Aamal Company, please refer to the corporate website: aamal.com.qa
Ebn Sina Medical Company:
Ebn Sina Medical is the leading pharmaceutical distribution company in Qatar with exclusive distribution agreements with more than 60 multinational pharmaceutical companies. It is active in the importation, distribution, promotion and retailing of pharmaceuticals, appliances and disposables in addition to consumer products.
Ebn Sina Medical provides complete professional services to government departments, retail pharmacies, private clinics, industrial companies and all the local market.
Alongside this professional knowledge and expertise, Ebn Sina Medical conforms to all Qatar regulatory requirements. and has implemented frequently updated quality management systems. Ebn Sina Medical is a registered trademark in Qatar.
© Press Release 2019